Food & Beverages Global On demand · 24-48h

Global Tomato Extract Market Strategic Research Report

Global Tomato Extract Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Tomato Extract Market
$1.01B2025
5.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Lycopene-standardized Extract, Carotenoid Complex Extract, Whole-spectrum Tomato Extract

By Application: Dietary Supplements, Food and Beverage, Cosmetics and Personal Care, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Lycored Corp., dsm-firmenich AG, Givaudan S.A., Indena S.p.A., Euromed S.A., Divi's Laboratories Limited, Vidya Herbs Private Limited, Sabinsa Corporation, Kagome Co., Ltd., Oryza Oil & Fat Chemical Co., Ltd., Fuji Chemical Industries Co., Ltd., Novarex Co., Ltd., Chenguang Biotech Group Co., Ltd., Xi'an Sost Biotech Co., Ltd., Shaanxi Undersun Biomedtech Co., Ltd., Hunan Nutramax Inc., Xi'an Natural Field Bio-Technique Co., Ltd., Shaanxi Jiahe Phytochem Co., Ltd., Xi'an Lyphar Biotech Co., Ltd., Zhejiang Medicine Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 127 pages
Market size 2025
$1.01B
Billion USD
Forecast CAGR
5.7%
2025-2032
Forecast 2032
$1.5B
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Tomato Extract market size is predicted to grow from US$ 1,008 million in 2025 to US$ 1,492 million in 2032; it is expected to grow at a CAGR of 5.7% from 2026 to 2032.

In 2025, global Tomato Extract production reached approximately 70 thousand tons, with an average global market price of around USD 14000 per ton.

The gross profit margin of major companies in the industry was approximately 22%–40%.

In 2025, global production capacity of Tomato Extract was approximately 90 thousand tons.

Tomato Extract is a concentrated functional ingredient derived from tomatoes through extraction, concentration, separation, and purification processes. It contains naturally occurring compounds such as lycopene, carotenoids, polyphenols, and other tomato-derived components and is supplied as powders, liquids, oleoresins, or standardized concentrates. Products are mainly used in dietary supplements, functional foods and beverages, cosmetics, nutraceutical formulations, food ingredients, and selected pharmaceutical applications.

The industrial chain of Tomato Extract includes upstream tomato cultivation, agricultural inputs, harvesting, tomato processing materials, solvents, and extraction auxiliaries; midstream covers crushing, extraction, separation, concentration, purification, drying, standardization, testing, and packaging; downstream applications mainly include dietary supplements, functional foods, beverages, nutraceuticals, cosmetics, food processing, pharmaceutical formulations, and other health-oriented products.

Tomato extract is a concentrated ingredient derived from tomatoes and containing naturally occurring compounds such as lycopene, carotenoids, and other bioactive components. Depending on formulation and concentration, it is used in dietary supplements, functional foods and beverages, cosmetics, personal care products, and selected food applications. Market development is supported by growing consumer interest in naturally derived functional ingredients, antioxidant-rich formulations, preventive wellness, and clean-label products. Improvements in extraction, concentration, purification, and stabilization technologies are helping manufacturers achieve more consistent active ingredient content and better stability in finished formulations. Lycopene-rich extracts remain an important segment, while opportunities are also emerging for standardized tomato-derived ingredients positioned for nutritional and cosmetic applications. Demand from functional nutrition, healthy aging products, and natural skincare formulations provides additional growth potential. However, raw tomato quality and seasonal supply can affect production consistency, while oxidation and stability of active components create formulation challenges. Competition from synthetic or alternative natural antioxidants, regulatory differences in health claims, and price sensitivity in mass-market applications can also constrain growth. Future development will emphasize standardized active content, improved bioavailability and stability, clean processing technologies, traceable sourcing, and stronger differentiation for specific nutritional and personal care applications.

This report presents a comprehensive overview of the global Tomato Extract market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Lycopene-standardized Extract
  • Carotenoid Complex Extract
  • Whole-spectrum Tomato Extract

Segment by Product Form

  • Powder Extract
  • Oil Suspension
  • Liquid and Emulsion Extract

Segment by Lycopene Content

  • Low-content(≤5%)
  • Medium-content(>5–15%)
  • High-content(>15%)

Segment by Application

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Tomato Extract market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Dietary Supplements, Food and Beverage, Cosmetics and Personal Care evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Tomato Extract Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.01B
2025
Forecast
$1.5B
2032
CAGR
5.7%
2025–2032
영역들
5
global
Key companies
Lycored Corp.dsm-firmenich AGGivaudan S.A.Indena S.p.A.Euromed S.A.Divi's Laboratories LimitedVidya Herbs Private LimitedSabinsa Corporation
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Lycopene-standardized ExtractCarotenoid Complex ExtractWhole-spectrum Tomato Extract
By Application
Dietary SupplementsFood and BeverageCosmetics and Personal CareOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Lycopene-standardized Extract
  • 3.1.3 Carotenoid Complex Extract
  • 3.1.4 Whole-spectrum Tomato Extract
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Dietary Supplements
  • 4.1.3 Food and Beverage
  • 4.1.4 Cosmetics and Personal Care
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Lycored Corp.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 dsm-firmenich AG
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Givaudan S.A.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Indena S.p.A.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Euromed S.A.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Divi's Laboratories Limited
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Vidya Herbs Private Limited
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Sabinsa Corporation
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Kagome Co., Ltd.
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Oryza Oil & Fat Chemical Co., Ltd.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Fuji Chemical Industries Co., Ltd.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Novarex Co., Ltd.
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Chenguang Biotech Group Co., Ltd.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Xi'an Sost Biotech Co., Ltd.
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Shaanxi Undersun Biomedtech Co., Ltd.
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Hunan Nutramax Inc.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Xi'an Natural Field Bio-Technique Co., Ltd.
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Shaanxi Jiahe Phytochem Co., Ltd.
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Xi'an Lyphar Biotech Co., Ltd.
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Zhejiang Medicine Co., Ltd.
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Tomato Extract market?
The global Tomato Extract market is estimated at US$ 1.01 billion in 2025 (base year) and is projected to reach US$ 1.49 billion by 2032.
What is the forecast CAGR for the Tomato Extract market?
The market is expected to grow at a CAGR of 5.7% from 2026 to 2032, expanding from US$ 1.01 billion in 2025 to US$ 1.49 billion in 2032, roughly 1.5 times its base-year value.
What is Tomato Extract?
In 2025, global Tomato Extract production reached approximately 70 thousand tons, with an average global market price of around USD 14000 per ton.
How is the Tomato Extract market segmented by type?
By type, the market is segmented into Lycopene-standardized Extract, Carotenoid Complex Extract and Whole-spectrum Tomato Extract.
What are the key applications of Tomato Extract?
Key applications covered include Dietary Supplements, Food and Beverage, Cosmetics and Personal Care and Other.
Which companies are profiled in the Tomato Extract market report?
Key players profiled include Lycored Corp., dsm-firmenich AG, Givaudan S.A., Indena S.p.A., Euromed S.A., Divi's Laboratories Limited, Vidya Herbs Private Limited and Sabinsa Corporation, among 20 companies covered in total.
What geographies does the Tomato Extract market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Tomato Extract?
Market development is supported by growing consumer interest in naturally derived functional ingredients, antioxidant-rich formulations, preventive wellness, and clean-label products.
What are the main risks and barriers in the Tomato Extract market?
However, raw tomato quality and seasonal supply can affect production consistency, while oxidation and stability of active components create formulation challenges.
Who should buy the Tomato Extract market report?
The report is intended for manufacturers and solution providers, distributors and end users in Dietary Supplements, Food and Beverage and Cosmetics and Personal Care, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Tomato Extract market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.